L
Lineage Cell Therapeutics Inc
XBER:BT3
Lineage Cell Therapeutics Inc
XBER:BT3
Price:
1.35
EUR
Market Cap:
€395.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
Triumph New Energy Co Ltd
F:LUG
|
CN |
|
Welcia Holdings Co Ltd
TSE:3141
|
JP |
|
Panthera Resources PLC
OTC:PATRF
|
UK |
|
V
|
Visa Inc
XHAM:3V64
|
US |
|
S
|
Suzano SA
F:SPXB
|
BR |
|
B.P. Marsh & Partners PLC
LSE:BPM
|
UK |
|
Walt Disney Co
NYSE:DIS
|
US |
|
Industrials REIT Ltd
LSE:MLI
|
UK |
|
T
|
Trane Technologies PLC
XBER:2IS
|
IE |
|
Alnylam Pharmaceuticals Inc
LSE:0HD2
|
US |
|
Retail Estates NV
F:R6N
|
BE |
|
I
|
Inovio Pharmaceuticals Inc
SWB:GBMB
|
US |
|
W
|
Wynn Resorts Ltd
XMUN:WYR
|
US |
|
Gol Linhas Aereas Inteligentes SA
BOVESPA:GOLL4
|
BR |
|
L
|
L3harris Technologies Inc
LSE:0L3H
|
US |
|
D
|
Denso Corp
DUS:DNO
|
JP |
|
Leone Film Group SpA
MIL:LFG
|
IT |
|
M
|
Micron Technology Inc
BMV:MU
|
US |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is hidden EUR. Compared with the current market price of 1.35 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BT3 Multiples-Based Value
LOCKED
